Cancer Hospital CAMS (Beijing)

Pékin · Oncologie · 3A · NCC

Fudan 2022 · #26 3A · NCC

Présentation

Cancer Hospital CAMS (Beijing) est un hôpital chinois de premier plan situé à Pékin, en Chine. Il figure dans le Top 100 MedTravelCN pour son excellence en Oncologie et sa capacité à accueillir des patients internationaux.

Host institution of the National Cancer Center; the flagship national institution for cancer research and standardized treatment.

Informations clés

Fondation1958
VillePékin
Spécialité phareOncologie
Accréditation3A · NCC
Rang Fudan 2022#26

Adresse et accès

No. 17 Panjiayuan Nanli, Chaoyang District, Beijing

Départements phares

Medical oncology Thoracic surgery Radiation oncology Pathology

Évolution du classement (référence Fudan, par paliers)

21-40
2021
11-20
2022
21-40
2023
21-40
2024
21-40
2025

Paliers établis d'après les éditions 2021-2025 du classement Fudan, à titre indicatif.

Experts représentatifs

  • Prof. He Jie · Thoracic surgery
  • He Jie · Academician, thoracic surgery
  • Xu Binghe · Academician, breast oncology
  • Shi Yuankai · Medical oncology, lymphoma & lung cancer
  • Wang Jie · Thoracic medical oncology
  • Ma Fei · Breast cancer precision therapy
  • Sun Yan · Senior academician, medical oncology

Experts compilés de sources publiques et des sites officiels ; disponibilités et titres peuvent évoluer — à vérifier auprès de l'hôpital avant tout rendez-vous.

Actualités et jalons

2011

National Cancer Center established at the hospital (2011)

2023

Breast-cancer expert Xu Binghe elected academician of CAE

2025

National cancer registry reports and early-screening programs continue

2011

National Cancer Center established

The National Cancer Center was established at the hospital, coordinating national cancer control, registry and screening programs.

2023

Xu Binghe elected CAE academician

Breast-cancer expert Xu Binghe was elected academician of the Chinese Academy of Engineering, strengthening the hospital's research leadership.

2024

Leads national cancer quality control

Through the National Cancer Center it drives national quality control, guideline rollout and grassroots support.

2025

Cancer registry annual report continues

Its annual China cancer registry reports provide the evidence base for national and international control policies.

2025

Research wards and innovative-drug trials expand

Research wards provide a regulated platform for drug and device trials, with eligibility assessment for patients.

2025

the Cancer Hospital CAMS holds a top position in the Fudan China Hospital Ranking

In the latest Fudan China Hospital Ranking, the Cancer Hospital CAMS holds the No.1 position in its category, with several specialties in the top specialty lists and a growing national referral volume.

2024

Cancer screening and precision therapy platforms improve

Screening and genomics-guided precision platforms keep improving, with a top national trial portfolio.

2024

National key clinical specialties keep expanding at the Cancer Hospital CAMS

The hospital hosts multiple national key clinical specialties spanning thoracic surgery, breast oncology and medical oncology, steadily strengthening complex care.

2024

Multidisciplinary clinics (MDT) offer one-stop care for complex cases

MDT clinics involving thoracic surgery, breast oncology and other specialties let complex patients receive a joint expert plan in a single visit.

2023

Internet hospital enables remote follow-up

The internet hospital of the Cancer Hospital CAMS supports online revisits, report interpretation and prescription delivery, cutting travel for distant patients.

2023

Cross-province direct medical insurance settlement fully covered

As a designated hospital for cross-province settlement, insured patients can settle bills directly on discharge, easing upfront costs.

2023

Day surgery and ERAS programs mature

Day surgery and enhanced recovery pathways let most routine procedures finish within 24 hours from admission to discharge.

2020

Played a major role in COVID-19 critical care

During the pandemic, the hospital sent successive medical teams to Hubei and other regions while running local critical care.

2022

Paired assistance and medical alliance support grassroots hospitals

Ongoing paired assistance and telemedicine collaboration upgrade grassroots capacity in thoracic surgery and beyond.

2024

A national base for residency training and medical talent

A major national residency training base, the hospital graduates large cohorts of residents, fellows and nurses under internationally aligned curricula.

2025

Clinical research and innovation keep accelerating

The hospital leads or joins numerous national multicenter trials, publishing in authoritative journals and translating findings into practice.

2025

International patient services keep improving

The international desk assists foreign patients with booking, interpretation, cost estimates and insurance, with streamlined workflows.

2022

Smart hospital and digital management recognized

Its smart service and management systems passed national reviews, improving integrated online-offline care.

2023

Nursing excellence and patient safety upgraded

Nursing quality and patient-safety programs were upgraded, with adverse-event monitoring and infection control meeting national standards.

2024

Medical education quality keeps improving

Expanded clinical skills centers apply simulation teaching and OSCE assessments widely.

Jalons compilés à partir de sources publiques fiables et de publications officielles ; les titres sont résumés.

Coopération internationale

  • Long-term research collaboration with MD Anderson Cancer Center, Institut Curie and other international centers.
  • As the host of the National Cancer Center, it maintains data exchange with IARC and other global bodies.
  • Faculty serve in international oncology societies and host visiting physicians from many countries.
  • Follow-up and health-management communities give overseas patients reminders, report interpretation and medication advice.
  • Faculty of the Cancer Hospital CAMS serve on committees, boards and journal editorial teams internationally, contributing to global guidelines.
  • The hospital hosts international congresses with regular visiting speakers from international cancer research institutions.
  • The hospital accepts international fellows; physicians from international cancer research institutions have completed structured training here.
  • As a teaching hospital, it provides clinical rotations for international medical students from many countries.
  • Cross-border teleconsultation and remote imaging reading are run with overseas medical institutions.
  • The hospital regularly dispatches medical aid teams to developing countries, treating patients and training local doctors.
  • A major choice for overseas Chinese returning for care, with full escort and multilingual services.
  • It takes part in Belt & Road health cooperation, with collaborative ties to hospitals along the routes.
  • Direct-billing agreements with multiple international insurers let foreign patients settle without upfront payment.
  • Joint laboratories and research centers with overseas universities drive collaborative science.
  • Findings keep appearing in authoritative international journals, raising the hospital's global visibility.
  • It keeps introducing advanced international technologies and devices with localized clinical studies.
  • Overseas hospital and health-administration delegations visit regularly in two-way management exchange.
  • Key staff are sent annually for advanced training at international cancer research institutions, lifting departmental capability on return.
  • Its quality and safety systems align with international standards, with some processes internationally certified.
  • Participation in international multicenter trials adds Chinese data for global patients.

Informations de coopération compilées de sources publiques ; se référer aux publications officielles de l'hôpital.

Partenariats universitaires

Peking Union Medical College

Recherche et publications

Runs national cancer registration and guideline programs and leads international multi-center oncology trials.

Informations de sources publiques (octobre 2026). Vérifiez sur le site officiel de l'hôpital avant votre voyage.

Consulter le parcours de soins médicaux ← Retour au classement des hôpitaux